Leslie Sloan
2022
In 2022, Leslie Sloan earned a total compensation of $1.1M as Former Chief Operating Officer at Aeglea BioTherapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $174,000 |
|---|---|
| Option Awards | $465,560 |
| Salary | $435,000 |
| Other | $13,323 |
| Total | $1,087,882 |
Sloan received $465.6K in option awards, accounting for 43% of the total pay in 2022.
Sloan also received $174K in non-equity incentive plan, $435K in salary and $13.3K in other compensation.
Rankings
In 2022, Leslie Sloan's compensation ranked 2,821st out of 5,542 executives tracked by ExecPay. In other words, Sloan earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,821 out of 5,542 | 49th |
Division Manufacturing | 1,566 out of 3,000 | 48th |
Major group Chemicals And Allied Products | 721 out of 1,350 | 47th |
Industry group Drugs | 671 out of 1,253 | 46th |
Industry Pharmaceutical Preparations | 483 out of 907 | 47th |
Source: SEC filing on October 26, 2023.
Sloan's colleagues
We found four more compensation records of executives who worked with Leslie Sloan at Aeglea BioTherapeutics in 2022.